Table of Content

Table of Contents

Global Oligonucleotide Therapeutics Market Outlook-by Major Company, Regions, Type, Application and Segment Forecast, 2015-2026
1 Market Scope Oligonucleotide Therapeutics
1.1 Oligonucleotide Therapeutics Market Snapsshot
1.1.1 Major Companies Overview
1.1.2 Market Concentration
1.1.3 Market Share & Six-Year Compound Annual Growth Rate of Major Market (CAGR)
2 Global Oligonucleotide Therapeutics Industry Analysis
2.1 Sector Breakdown Assessment, 2015-2026
2.2 Market Assessment by Type
2.3 Market Size Analysis and Forecast, by Application
3 China Oligonucleotide Therapeutics Market Estimates & Forecasts
3.1 China Oligonucleotide Therapeutics Market by Sector, 2015-2026
3.2 China Oligonucleotide Therapeutics Market by Application, 2015-2026
4 EU Oligonucleotide Therapeutics Market Estimates & Forecasts
4.1 EU Oligonucleotide Therapeutics Market by Sector, 2015-2026
4.2 EU Oligonucleotide Therapeutics Market by Application, 2015-2026
5 USA Oligonucleotide Therapeutics Market Estimates & Forecasts
5.1 USA Oligonucleotide Therapeutics Market by Sector, 2015-2026
5.2 USA Oligonucleotide Therapeutics Market by Application, 2015-2026
6 Japan Oligonucleotide Therapeutics Market Estimates & Forecasts
6.1 Japan Oligonucleotide Therapeutics Market by Sector, 2015-2026
6.2 Japan Oligonucleotide Therapeutics Market by Application, 2015-2026
7 India Oligonucleotide Therapeutics Market Estimates & Forecasts
7.1 India Oligonucleotide Therapeutics Market by Sector, 2015-2026
7.2 India Oligonucleotide Therapeutics Market by Application, 2015-2026
8 Southeast Asia Oligonucleotide Therapeutics Market Estimates & Forecasts
8.1 Southeast Asia Oligonucleotide Therapeutics Market by Sector, 2015-2026
8.2 Southeast Asia Oligonucleotide Therapeutics Market by Application, 2015-2026
9 South America Oligonucleotide Therapeutics Market Estimates & Forecasts
9.1 South America Oligonucleotide Therapeutics Market by Sector, 2015-2026
9.2 South America Oligonucleotide Therapeutics Market by Application, 2015-2026
10 Value Chain (Impact of COVID-19)
10.1 Oligonucleotide Therapeutics Value Chain Analysis
10.1.1 Downstream
10.2 COVID-19 Impact on this Industry
10.2.1 Industrial Policy Issued Under the Epidemic Situation
10.3 Driver
10.4 Opportunity

11 Competitive Analysis
11.1 PCI Biotech
11.1.1 Key Information
11.1.2 Service/Solution Introduction
11.1.3 Financials
11.1.4 Business Dynamics
11.2 SomaGenics
11.2.1 Key Information
11.2.2 Service/Solution Introduction
11.2.3 Financials
11.2.4 Business Dynamics
11.3 ContraVir
11.3.1 Key Information
11.3.2 Service/Solution Introduction
11.3.3 Financials
11.3.4 Business Dynamics
11.4 Alnylam
11.4.1 Key Information
11.4.2 Service/Solution Introduction
11.4.3 Financials
11.4.4 Business Dynamics
11.5 Regulus Therapeutics
11.5.1 Key Information
11.5.2 Service/Solution Introduction
11.5.3 Financials
11.5.4 Business Dynamics
11.6 Ionis Pharmaceuticals
11.6.1 Key Information
11.6.2 Service/Solution Introduction
11.6.3 Financials
11.6.4 Business Dynamics
11.7 Gilead
11.7.1 Key Information
11.7.2 Service/Solution Introduction
11.7.3 Financials
11.7.4 Business Dynamics
11.8 Santaris
11.8.1 Key Information
11.8.2 Service/Solution Introduction
11.8.3 Financials
11.8.4 Business Dynamics
11.9 InteRNA
11.9.1 Key Information
11.9.2 Service/Solution Introduction
11.9.3 Financials
11.9.4 Business Dynamics
11.10 miRage
11.10.1 Key Information
11.10.2 Service/Solution Introduction
11.10.3 Financials
11.10.4 Business Dynamics
11.11 Biogen
11.12 Merck
11.13 Pfizer
12 Research Conclusion

List of Figure

List of Tables and Figures

Table Revenue (Million USD) of Major Players (2015-2020)
Figure Oligonucleotide Therapeutics Revenue Market Share of Top 5 Players
Table Market Share & CAGR of Major Market (2021-2026)
Figure Regional Market Share in Terms of Revenue (2019 - 2020)
Table CAGR in Terms of Revenue of Each Type (2015-2026)
Table Global Oligonucleotide Therapeutics Revenue (Million USD) by Type (2015-2026)
Figure Global Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2015-2026)
Figure Global Oligonucleotide Therapeutics Revenue Market Share (%) by Type (2019 – 2020)
Figure Market Assessment by Type
Table Historical & Forecast Oligonucleotide Therapeutics Different Application Field Revenue (Million USD)
Table China Oligonucleotide Therapeutics Market Estimates & Forecasts by Sector (2015-2026)
Figure China Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2015-2026)
Figure Market Assessment by Type (2019-2020)
Table Historical & Forecast Oligonucleotide Therapeutics Different Application Field Revenue (Million USD)
Figure Different Application Field Revenue Market Share (%) (2019 – 2020)
Table US Oligonucleotide Therapeutics Market Estimates & Forecasts by Sector (2015-2026)
Figure US Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2015-2026)
Figure Market Assessment by Type (2019-2020)
Table Historical & ForecastOligonucleotide TherapeuticsDifferent Application Field Revenue (Million USD)
Figure Different Application Field Revenue Market Share (%) (2019 – 2020)
Table Europe Oligonucleotide Therapeutics Market Estimates & Forecasts by Sector (2015-2026)
Figure Europe Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2015-2026)
Figure Market Assessment by Type (2019-2020)
Table Historical & Forecast Oligonucleotide Therapeutics Different Application Field Revenue (Million USD)
Figure Different Application Field Revenue Market Share (%) (2019 – 2020)
Table Japan Oligonucleotide Therapeutics Market Estimates & Forecasts by Sector (2015-2026)
Figure Japan Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2015-2026)
Figure Market Assessment by Type (2019-2020)
Table Historical & Forecast Oligonucleotide Therapeutics Different Application Field Revenue (Million USD)
Figure Different Application Field Revenue Market Share (%) (2019 – 2020)
Table Southeast Asia Oligonucleotide Therapeutics Market Estimates & Forecasts by Sector (2015-2026)
Figure Southeast Asia Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2015-2026)
Figure Market Assessment by Type (2019-2020)
Table Historical & Forecast Oligonucleotide Therapeutics Different Application Field Revenue (Million USD)
Figure Different Application Field Revenue Market Share (%) (2019 – 2020)
Table South America Oligonucleotide Therapeutics Market Estimates & Forecasts by Sector (2015-2026)
Figure South America Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2015-2026)
Figure Market Assessment by Type (2019-2020)
Table Historical & Forecast Oligonucleotide Therapeutics Different Application Field Revenue (Million USD)
Figure Different Application Field Revenue Market Share (%) (2019 – 2020)
Figure Value Chain Structure of Oligonucleotide Therapeutics
Table Value Chain
Table Key Downstream Customer in Each Application Field
Table Industry News List of Oligonucleotide Therapeutics
Table PCI Biotech Key Information
Table Oligonucleotide Therapeutics Revenue (Million USD) of PCI Biotech (2015-2020)
Figure PCI Biotech Service/Solution Introduction
Table SomaGenics Key Information
Table Oligonucleotide Therapeutics Revenue (Million USD) of SomaGenics (2015-2020)
Figure SomaGenics Service/Solution Introduction
Table ContraVir Key Information
Table Oligonucleotide Therapeutics Revenue (Million USD) of ContraVir (2015-2020)
Figure ContraVir Service/Solution Introduction
Table Alnylam Key Information
Table Oligonucleotide Therapeutics Revenue (Million USD) of Alnylam (2015-2020)
Figure Alnylam Service/Solution Introduction
Table Regulus Therapeutics Key Information
Table Oligonucleotide Therapeutics Revenue (Million USD) of Regulus Therapeutics (2015-2020)
Figure Regulus Therapeutics Service/Solution Introduction
Table Ionis Pharmaceuticals Key Information
Table Oligonucleotide Therapeutics Revenue (Million USD) of Ionis Pharmaceuticals (2015-2020)
Figure Ionis Pharmaceuticals Service/Solution Introduction
Table Gilead Key Information
Table Oligonucleotide Therapeutics Revenue (Million USD) of Gilead (2015-2020)
Figure Gilead Service/Solution Introduction
Table Santaris Key Information
Table Oligonucleotide Therapeutics Revenue (Million USD) of Santaris (2015-2020)
Figure Santaris Service/Solution Introduction
Table InteRNA Key Information
Table Oligonucleotide Therapeutics Revenue (Million USD) of InteRNA (2015-2020)
Figure InteRNA Service/Solution Introduction
Table miRage Key Information
Table Oligonucleotide Therapeutics Revenue (Million USD) of miRage (2015-2020)
Figure miRage Service/Solution Introduction
Table Biogen Key Information
Table Oligonucleotide Therapeutics Revenue (Million USD) of Biogen (2015-2020)
Figure Biogen Service/Solution Introduction
Table Merck Key Information
Table Oligonucleotide Therapeutics Revenue (Million USD) of Merck (2015-2020)
Figure Merck Service/Solution Introduction
Table Pfizer Key Information
Table Oligonucleotide Therapeutics Revenue (Million USD) of Pfizer (2015-2020)
Figure Pfizer Service/Solution Introduction